Prior COVID‐19 was not associated with a higher risk for complications during and after pharmacologic myocardial perfusion imaging stress testing, data from a large claims database analysis show. “Depending on the local setting, COVID‐19 incidence and availability, the use of pharmacologic myocardial perfusion imaging may be recommended instead of an exercise stress test to